Abstract:Gut microbiota-derived endotoxin has been linked to human nonalcoholic fatty liver disease (NAFLD), but the specific causative agents and their molecular mechanisms remain elusive. In this study, we investigated whether bacterial strains of endotoxin-producing pathogenic species overgrowing in obese human gut can work as causative agents for NAFLD. We further assessed the role of lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) cross talk in this pathogenicity. Nonvirulent strains of Gram-negative pathobionts were isolated from obese human gut and monoassociated with C57BL/6J germfree (GF) mice fed a high-fat diet (HFD). Deletion of waaG in the bacterial endotoxin synthetic pathway and knockout of TLR4 in GF mice were used to further study the underlying mechanism for a causal relationship between these strains and the development of NAFLD. Three endotoxin-producing strains, Enterobacter cloacae B29, Escherichia coli PY102, and Klebsiella pneumoniae A7, overgrowing in the gut of morbidly obese volunteers with severe fatty liver, induced NAFLD when monoassociated with GF mice on HFD, while HFD alone did not induce the disease in GF mice. The commensal Bacteroides thetaiotaomicron (ATCC 29148), whose endotoxin activity was markedly lower than that of Enterobacteriaceae strains, did not induce NAFLD in GF mice. B29 lost its proinflammatory properties and NAFLD-inducing capacity upon deletion of the waaG gene. Moreover, E. cloacae B29 did not induce NAFLD in TLR4-deficient GF mice. These nonvirulent endotoxin-producing strains in pathobiont species overgrowing in human gut may work as causative agents, with LPS-TLR4 cross talk as the most upstream and essential molecular event for NAFLD.IMPORTANCE Recent studies have reported a link between gut microbiota and nonalcoholic fatty liver disease (NAFLD), showing that germfree (GF) mice do not develop metabolic syndromes, including NAFLD. However, the specific bacterial species causing NAFLD, as well as their molecular cross talk with the host for driving liver disease, remain elusive. Here, we found that nonvirulent endotoxin-producing strains of pathogenic species overgrowing in obese human gut can act as causative agents for induction of NAFLD and related metabolic disorders. The cross talk between endotoxin from these specific producers and the host's TLR4 receptor is the most upstream and essential molecular event for inducing all phenotypes in NAFLD and related metabolic disorders. These nonvirulent endotoxin-producing strains of gut pathogenic species overgrowing in human gut may collectively become a predictive biomarker or serve as a novel therapeutic target for NAFLD and related metabolic disorders.

Endotoxin-producing Gut Opportunistic Pathogens as Causative Agents for Human Obesity

An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice

Endotoxin Producers Overgrowing in Human Gut Microbiota As the Causative Agents for Nonalcoholic Fatty Liver Disease

Microbiome–Gut Dissociation: Investigating the Origins of Obesity

The Gut Microbiota and Obesity: from Correlation to Causality

An obesity-associated gut microbiome with increased capacity for energy harvest

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

The Effect of Enteric-Derived Lipopolysaccharides on Obesity

High-fat-diet-induced gut microbiome changes in mice

The gut microbiota, obesity and insulin resistance

High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway

Regulated Inflammation and Lipid Metabolism in Colon Mrna Expressions of Obese Germfree Mice Responding to Enterobacter Cloacae B29 Combined with the High Fat Diet

Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

The human gut microbiota: Metabolism and perspective in obesity

The gut microbiota obesity: from correlation to causality

The critical role of gut microbiota in obesity

Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

The Role of the Gut Microbiota in Energy Metabolism and Metabolic Disease

Gut Dysbiosis and Adaptive Immune Response in Diet-induced Obesity vs. Systemic Inflammation

Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet